Hypor and Danish Genetics form a strategic alliance
Global swine breeder Hypor is merging with Danish Genetics and partners. That was announced earlier this week by both parties. It is expected that the deal will be fully closed by early 2025.
Hypor is the pig division of the multispecies genetics company Hendrix Genetics, headquartered in the Netherlands and active in 100 countries worldwide. Danish Genetics was founded in Denmark in August 2018, when various players in the Danish pig breeding programme went their own way; the company is active in 40 countries around the world.
In a press release, both companies speak of a “significant milestone,” which would mark “the establishment of a strategic partnership aimed at enhancing their collective presence in the global swine genetics market and unlocking new opportunities.”
As a result of the merger, Hendrix Genetics will hold a majority stake and Danish Genetics and partners will hold a significant part of the newly formed entity.
Expanding portfolios
According to the press release, the merger would “represent a powerful collaboration,” which is “designed to create a strong partnership that expands their current product portfolios, leverages cutting-edge technologies and enhances their global distribution networks.”
Richard Maatman, Hendrix Genetics’ CEO, speaks of a step that fits in the mother company’s strategy. “By integrating our resources with Danish Genetics, we can capitalise on our combined expertise and R&D capabilities to drive innovation and deliver exceptional value to our customers in the swine industry. Together, we are poised to set new standards for performance and sustainability in swine genetics.”
Jan Gerber, CEO of Danish Genetics, shared in his enthusiasm, saying, “By combining our resources and shared commitments to innovation and animal welfare, we aim to deliver advanced products that support producers in achieving higher performance. With a global reach, this partnership will allow us to serve our customers even more effectively across the globe.”
Parties anticipate closing the transaction in early 2025. Both Hypor and Danish Genetics stated to be “dedicated to ensuring a seamless transition for all stakeholders and building a lasting, prosperous partnership.”
